The Cannigma

JULY 1, 2022

What if most of it is not based on the level of scientific certainty that cannabis marketing teams and media outlets would have us believe? Because of this variability in the plant, and because of a lack of standard methods–like chemical analyses of cannabinoids or terpenes–has led to inconsistent scientific results. Types of Research.

Research and Development 124

Research and Development Data THC Clinical Trials 124

The Cannigma

JUNE 24, 2021

The constant distractions, notifications, and social media outrages of the day can also boost your anxiety and stress, and make it much harder to just live in the moment. Cannabinoids may ease nausea and vomiting. Isolated on their own, each of these cannabinoids and terpenes may have unique, therapeutic effects.

CBD 101

CBD Microdosing Edibles Sleep 101

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020.

Pharmaceutical 51

Pharmaceutical Clinical Trials Research and Development Programs 51

Cannabis Info

OCTOBER 11, 2019

In the Australian clinical study, cannabinoids will be extracted and delivered in a mouth spray, making it easier to be administered to the elderly. The clinical trial will be held over a 14-month period starting early next year. The findings won scant media attention, but the medical community definitely took note.

Treatment 45

Treatment Clinical Trials Cannabinoids Cannabis 45

Cannabis Law Report

JANUARY 6, 2022

Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse, announced today that it has appointed Scott L. AUSTIN, Texas–(BUSINESS WIRE)– Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Cannabinoids Programs 52

Otherside Farms

NOVEMBER 3, 2019

The “entourage effect” is the latest buzz in cannabis media, presenting a well-formed scientific hypothesis that cannabinoids don’t just work on their own. They work in tandem with a bunch of other cannabinoids, terpenoids, and flavonoids. It is a non-psychoactive cannabinoid that modulates the effect of psychoactive THC.

Terpenes 58

Terpenes CBD Research and Development Cannabinoids 58

Cannabis Law Report

OCTOBER 12, 2021

Their audacious vision to reimagine traditional pharma efficacy trials promises to rapidly and accurately determine which nutraceuticals and natural molecules actually work for which conditions,” said Diamandis. Radicle Science also announced a new CTO, Sheldon Borkin , PhD, who joined in September 2021.

Clinical Trials 40

Clinical Trials Research and Development Sleep Cannabinoids 40

Cannabis Law Report

NOVEMBER 16, 2019

Scheme (SAS), Authorised Prescriber Scheme and clinical trials; (b) the suitability of the Pharmaceutical Benefits Scheme for subsidising patient access to medicinal cannabis products; (c) the interaction between state and territory authorities and the Commonwealth, including overlap and variation between. Media Releases.

Clinical Trials 58

Clinical Trials Access Medicine Patients 58

Cannabis Law Report

SEPTEMBER 22, 2021

New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced new data demonstrating Supera-CBD’s superior potency over CBD by factor of 8,000 times.

Pharmaceutical 40

Pharmaceutical Data CBD Clinical Trials 40

Cannabis Law Report

OCTOBER 15, 2021

At Kidney Week 2021, Goldfinch Bio will present multiple e-posters, including: The design of TRACTION-2, the ongoing Phase 2 clinical trial evaluating GFB-887 for the treatment of focal segmental glomerulosclerosis (FSGS) and diabetic nephropathy (DN). Media: Liz Melone. Visit us at www.goldfinchbio.com to learn more.

Clinical Trials 40

Clinical Trials Research and Development Data Patients 40

Cannabis Law Report

SEPTEMBER 1, 2019

I actually produce more natural cannabinoids than the average person – that’s helped me recover from seven strokes,” says Elisabetta Faenza, now CEO of Australian medicinal cannabis company LeafCann. The clinical trials and the standard of production could lead the world.”. But not everyone agrees. “I

Clinical Trials 53

Clinical Trials Research and Development Medicine Cultivation 53

Cannabis Law Report

OCTOBER 5, 2021

The review excludes pre-clinical trials (i.e. Professor Mark Connor is a molecular pharmacologist with expertise in analgesics and psychoactive drugs, particularly cannabinoids and opioids, with extensive research experience in the USA, UK, and Australia. experimental pharmacology studies in test tube or animal models).

Treatment 52

Treatment Conditions Medicine Clinical Trials 52

Cannabis Law Report

DECEMBER 7, 2021

“Despite the massive and growing market size, there is still scant data on the effectiveness of over-the-counter cannabinoid products due to the cost, speed and scale limitations of the current approach to scientific research,” said Jeff Chen, MD/MBA, Co-founder and CEO of Radicle Science. Media Contact: Eric Schudiske ( eric@s2spr.com ).

Clinical Trials 40

Clinical Trials CBD Data Sleep 40

Cannabis Law Report

JANUARY 24, 2022

Accomplished leader to oversee Goldfinch Bio’s clinical function to advance precision medicines for people living with kidney disease. Company is on track to announce interim data in mid-2022 from its Phase 2 clinical trial for lead kidney precision medicine product candidate GFB-887. Media: Liz Melone. CAMBRIDGE, Mass.–(BUSINESS

Clinical Trials 40

Clinical Trials Research and Development Data Medicine 40

MMJ Recs

JULY 3, 2024

From the pressures of work and personal relationships to the constant bombardment of information on social media and the news, many individuals find themselves struggling to cope with these challenges. We live in a fast-paced world making anxiety and stress become a pervasive issue affecting the mental health of many US citizens.

CBD 52

CBD Research and Development Clinical Trials THC 52

MMJ Recs

DECEMBER 22, 2023

One of the key drivers of this shift is the increasing body of scientific research highlighting the medical properties of cannabinoids, the active compounds in marijuana. The changing face of cannabis in popular media, literature, and entertainment has contributed to a more nuanced understanding of its potential benefits.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

JANUARY 11, 2019

Furthermore, by redefining hemp to include its “extracts, cannabinoids and derivatives,” Congress explicitly removed popular hemp products – such as hemp-derived CBD — from the purview of the CSA. 9] While that portion of the statement provoked a few breathless media reports, it was old news. There is still work to be done.

Hemp 49

Hemp CBD Law Seed-To-Sale 49

Cannabis Law Report

OCTOBER 29, 2021

The highlights for the quarter are: As previously disclosed, on September 7, 2021, the Company announced the completion of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”) based investigational new drug, IGC-AD1, intended to alleviate certain symptoms of individuals who have Alzheimer’s disease.

Clinical Trials 40

Clinical Trials Research and Development Data Business 40

Cannabis Law Report

DECEMBER 6, 2021

“We look forward to Jeff’s significant contributions heading into another year of continued growth and progress for Goldfinch Bio, including a planned interim data readout from TRACTION-2, the ongoing Phase 2 clinical trial of our lead precision kidney medicine candidate, in mid-2022.”. Media: Liz Melone. 212-362-1200.

Research and Development 40

Research and Development Supply Chain Clinical Trials Medicine 40

Puff Puff Post

SEPTEMBER 16, 2019

This new initiative developed by Santé Cannabis equips physicians with the most up-to-date clinical guidelines, support networks, online and in-person training opportunities so they can prescribe and monitor cannabinoid treatment plans with confidence. Clinical toolkits to help navigate patient assessment and follow-ups.

Programs 40

Programs Research and Development Education Treatment 40

The Joint Blog

JULY 25, 2020

Lately, CBD has warranted a huge share of public and media attention for its perceived benefits to health and well-being. The agency maintains that they need more time to probe further into the science of cannabidiol, which will require thorough research and clinical trials before they can conclude certain products as GRAS. “To

CBD 33

CBD Clinical Trials Safety Media 33

Cannabis Law Report

NOVEMBER 24, 2021

Media representations can offer insights into the nature of the discourse about new medical products and therapies and how ideas and understandings about social phenomena become constructed. This article analyses media representations of medicinal cannabis in Australian medical publications. Media framing of cannabis.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JULY 23, 2019

After using Koi’s products, Thurston was given a random drug test by her employer, which came back positive for cannabinoids. It is important that they conduct medical research into the safety and effectiveness of cannabis products through adequate and well-controlled clinical trials. She lost her job as a result.

Law 40

Law Clinical Trials CBD Edibles 40

SpeedWeed

DECEMBER 28, 2018

Marinol (synthetic THC) has been available by prescription since 1986, and other synthetic cannabinoid drugs are in the works, but Epidiolex is the first plant-derived pharmaceutical to reach the US market. She claims that when Antifa activists publicized her posts to social media and message boards, they took them “out of context.”

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

FloridaMarijuana.net

JUNE 13, 2018

Additionally, the NCI recognizes that cannabinoids “may have benefits in the treatment of cancer-related side effects.”. Mainstream media has begun to illustrate just how effective medical marijuana can be in helping cancer patients. Cannabinoids are extracted from the cannabis plant and an extract oil is created.

Clinical Trials 189

Clinical Trials Marijuana Patients Chronic Pain 189

Cannabis Law Report

JULY 8, 2021

About Enveric Biosciences Enveric Biosciences is a patient-first biotechnology company developing rigorously tested, novel cannabinoid medicines to improve quality of life for cancer patients. Media Contacts Caitlin Kasunich / Raquel Cona KCSA Strategic Communications 212.896.1241 / 212.896.1204 ckasunich@kcsa.com / rcona@kcsa.com.

Treatment 98

Treatment Clinical Trials CBD Patients 98

FloridaMarijuana.net

AUGUST 13, 2018

Even mainstream media has delved into the medicinal properties of cannabis and the science-based culture that cannabis heals. Published in 2016, “ Cannabis and Cannabinoid Research,” written by Michelle Sexton, Carrie Cuttler, John S. They found no associations between depression/anxiety and cannabis use onset. Finnell and Laurie K.

Marijuana 145

Marijuana Patients Clinical Trials Conditions 145

Cannabis Law Report

SEPTEMBER 29, 2021

ANANDA is a leading research-focused biotech company pioneering high-caliber clinical studies evaluating therapeutic targets for cannabinoids. ANANDA Scientific Media Relations | Christopher Moore | 813 326 4265 | media@anandascientific.com. GREENWOOD VILLAGE, Colo. & ABOUT ANANDA SCIENTIFIC.

Clinical Trials 40

Clinical Trials Medicine Treatment Research and Development 40

CannaMD

NOVEMBER 6, 2019

Perhaps the commercialization of marijuana and the favorable media coverage surrounding the health effects of marijuana are fostering such a perception. Those who received the cannabinoid medication Dronabinol had shorter lengths of stay and consumed fewer opioids. Marijuana Preferred Over Pain Pills. Study author, Thomas R.

Marijuana 107

Marijuana Patients Clinical Trials Data 107

The Cannigma

APRIL 8, 2021

Yeah, there are thousands of strains, but those thousands of strains, but those thousands of strains only make let’s say one or two of 60 cannabinoids in abundance. Half of those cannabinoids of plant doesn’t make or three quarters because they’re byproducts. This is by nature of the way we consume cannabinoids.

Medicine 135

Medicine Cannabinoids Cannabis THC 135

CannaMD

MARCH 8, 2021

Lastly, by imposing an arbitrary potency cap on just one of marijuana’s 100-plus cannabinoids, H.B. Instead of restricting free speech, the FTC recommends parents practice “media literacy.”. Cesamet, like dronabinol-containing products, is indicated for nausea associated with cancer chemotherapy. How to learn more.

THC 116

THC Research and Development Treatment Patients 116

Cannabis Law Report

SEPTEMBER 24, 2019

Cannabidiol oral solution contains highly purified, plant-derived cannabidiol (CBD), a cannabinoid lacking the “high” associated with cannabis. We are very happy that patients will now have access to a much-needed, new treatment option, and one routed through a rigorous clinical trials programme and licensed by the EMA.”.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Weedistry

JANUARY 28, 2019

Cannabinoid-derived product by Ontario-based Tetra Bio-Pharma to be officially recognized as a drug. It’s when presented with personal stories like that of the Rhodes family and the stream of alarming data that the significance of Tetra Bio-Pharma’s (TBP) clinical trials is worth exploring.

Clinical Trials 40

Clinical Trials Research and Development Chronic Pain Data 40

Alchimia

JANUARY 25, 2022

At the beginning of this new year of 2022, a news story about how cannabis can help fight COVID-19 was picked up by many non-cannabis media. While this research is certainly worth celebrating, the reality behind the message can be easily misunderstood in this age of social media.

Research and Development 98

Research and Development Terpenes CBD Treatment 98

NORML

SEPTEMBER 20, 2019

Essentially, the federal government has monopolized cannabis research, and ElSohly’s product, according to some scientists who’ve seen it, is unsuitable for clinical trials. The testing did confirm that the [batch sent by NIDA] has cannabinoids, some very minute quantities of terpenes in it, and that it was cannabis.

DEA 220

DEA Research and Development Clinical Trials Patients 220

Cannabis Law Report

JUNE 4, 2021

Our proprietary ranking system takes into account: Social reach (social media, blogs, podcasts, publications, etc.). Through his social media outlets, podcast, blog, and interviews, Tim has educated hundreds of millions of people about psychedelics. This list is focused on those who have had the largest impact for 2021. . Followers.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51